Due to the potential for high insulin levels caused by insulinoma to promote rapid progression of breast cancer, and the patient's recurrent hypoglycemic symptoms, a multidisciplinary team (MDT) discussion at our hospital suggested addressing the insulinoma with minimal invasiveness as a priority. The gene discussed is INS; the disease is pancreatic insulinoma.